Inositol

ALIMENTARY TRACT AND METABOLISM

Key facts

Inositol is a drug catalogued in DrugCentral. Recorded indications include Hypercholesterolemia, Hypertriglyceridemia, Hypoalphalipoproteinemia and Mixed hyperlipidemia.

• Indications: Hypercholesterolemia, Hypertriglyceridemia, Hypoalphalipoproteinemia, Mixed hyperlipidemia and Myocardial Reinfarction Prevention and others.
• ATC code: A11HA07 (Other plain vitamin preparations).
• Molecular formula: C6H12O6; molecular weight 180.16 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (8)

• Hypercholesterolemia
• Hypertriglyceridemia
• Hypoalphalipoproteinemia
• Mixed hyperlipidemia
• Myocardial Reinfarction Prevention
• Niacin deficiency
• Pellagra
• Slow Progression of Coronary Artery Disease

Off-label uses (1)

• Hyperlipidemia

Contraindications (20)

• Acute cerebrovascular insufficiency
• Acute coronary syndrome
• Alcoholism
• Arterial hemorrhage
• Blood coagulation disorder
• Breastfeeding (mother)
• Cerebral infarction
• Cerebrovascular accident
• Diabetes mellitus
• Disease of liver
• Disorder of coronary artery
• Gout
• Hyperglycemia
• Hypophosphatemia
• Liver function tests abnormal
• Low blood pressure
• Myocardial infarction
• Peptic ulcer
• Pregnancy, function
• Thrombocytopenic disorder

Regulatory approvals (1)

Date	Agency	Marketed as	Applicant	Orphan
—	FDA	—	—

ATC classification

ATC code	Therapeutic hierarchy
A11HA07	ALIMENTARY TRACT AND METABOLISM › VITAMINS › OTHER PLAIN VITAMIN PREPARATIONS › Other plain vitamin preparations

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA term	LLR
Lip dry	93.1
Needle fatigue	90.1
Gait spastic	85.8
Relapsing-remitting multiple sclerosis	80.2
C-reactive protein abnormal	79.0
Back disorder	73.4
Adjustment disorder with depressed mood	66.5
Monoparesis	66.2
Dislocation of vertebra	64.7
Injury	64.5
Rheumatoid factor positive	62.7
Hypertonic bladder	60.6

Chemical structure

• Molecular formula: C₆H₁₂O₆
• Molecular weight: 180.16 g/mol
• CAS number: 87-89-8
• InChIKey: CDAISMWEOUEBRE-GPIVLXJGSA-N
• PubChem CID: 892

O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Inositol used for?

DrugCentral lists the following indications for Inositol: Hypercholesterolemia, Hypertriglyceridemia, Hypoalphalipoproteinemia, Mixed hyperlipidemia, Myocardial Reinfarction Prevention, Niacin deficiency, Pellagra and Slow Progression of Coronary Artery Disease.

What is the chemical formula of Inositol?

Inositol has the molecular formula C6H12O6 and a molecular weight of 180.16 g/mol.

Sources

• DrugCentral drug card 1444 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
• ChEMBL CHEMBL1222251 — compound record and bioactivity
• PubChem CID 892 — chemical identifiers
• DrugBank DB13178 — drug record
• FDA UNII 4L6452S749 — substance identity
• DailyMed: FDA labels for Inositol — current prescribing information (label search)
• FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral

How this page is built: methodology · editorial policy & corrections.